Cargando…

The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease

In Parkinson’s disease, there is a progressive reduction in striatal dopaminergic function, and loss of neuromelanin-containing dopaminergic neurons and increased iron deposition in the substantia nigra. We tested the hypothesis of a relationship between impairment of the dopaminergic system and cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Biondetti, Emma, Santin, Mathieu D, Valabrègue, Romain, Mangone, Graziella, Gaurav, Rahul, Pyatigorskaya, Nadya, Hutchison, Matthew, Yahia-Cherif, Lydia, Villain, Nicolas, Habert, Marie-Odile, Arnulf, Isabelle, Leu-Semenescu, Smaranda, Dodet, Pauline, Vila, Miquel, Corvol, Jean-Christophe, Vidailhet, Marie, Lehéricy, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634084/
https://www.ncbi.nlm.nih.gov/pubmed/33978742
http://dx.doi.org/10.1093/brain/awab191
_version_ 1784608064544964608
author Biondetti, Emma
Santin, Mathieu D
Valabrègue, Romain
Mangone, Graziella
Gaurav, Rahul
Pyatigorskaya, Nadya
Hutchison, Matthew
Yahia-Cherif, Lydia
Villain, Nicolas
Habert, Marie-Odile
Arnulf, Isabelle
Leu-Semenescu, Smaranda
Dodet, Pauline
Vila, Miquel
Corvol, Jean-Christophe
Vidailhet, Marie
Lehéricy, Stéphane
author_facet Biondetti, Emma
Santin, Mathieu D
Valabrègue, Romain
Mangone, Graziella
Gaurav, Rahul
Pyatigorskaya, Nadya
Hutchison, Matthew
Yahia-Cherif, Lydia
Villain, Nicolas
Habert, Marie-Odile
Arnulf, Isabelle
Leu-Semenescu, Smaranda
Dodet, Pauline
Vila, Miquel
Corvol, Jean-Christophe
Vidailhet, Marie
Lehéricy, Stéphane
author_sort Biondetti, Emma
collection PubMed
description In Parkinson’s disease, there is a progressive reduction in striatal dopaminergic function, and loss of neuromelanin-containing dopaminergic neurons and increased iron deposition in the substantia nigra. We tested the hypothesis of a relationship between impairment of the dopaminergic system and changes in the iron metabolism. Based on imaging data of patients with prodromal and early clinical Parkinson’s disease, we assessed the spatiotemporal ordering of such changes and relationships in the sensorimotor, associative and limbic territories of the nigrostriatal system. Patients with Parkinson’s disease (disease duration < 4 years) or idiopathic REM sleep behaviour disorder (a prodromal form of Parkinson’s disease) and healthy controls underwent longitudinal examination (baseline and 2-year follow-up). Neuromelanin and iron sensitive MRI and dopamine transporter single-photon emission tomography were performed to assess nigrostriatal levels of neuromelanin, iron, and dopamine. For all three functional territories of the nigrostriatal system, in the clinically most and least affected hemispheres separately, the following was performed: cross-sectional and longitudinal intergroup difference analysis of striatal dopamine and iron, and nigral neuromelanin and iron; in Parkinson’s disease patients, exponential fitting analysis to assess the duration of the prodromal phase and the temporal ordering of changes in dopamine, neuromelanin or iron relative to controls; and voxel-wise correlation analysis to investigate concomitant spatial changes in dopamine-iron, dopamine-neuromelanin and neuromelanin-iron in the substantia nigra pars compacta. The temporal ordering of dopaminergic changes followed the known spatial pattern of progression involving first the sensorimotor, then the associative and limbic striatal and nigral regions. Striatal dopaminergic denervation occurred first followed by abnormal iron metabolism and finally neuromelanin changes in the substantia nigra pars compacta, which followed the same spatial and temporal gradient observed in the striatum but shifted in time. In conclusion, dopaminergic striatal dysfunction and cell loss in the substantia nigra pars compacta are interrelated with increased nigral iron content.
format Online
Article
Text
id pubmed-8634084
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86340842021-12-01 The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease Biondetti, Emma Santin, Mathieu D Valabrègue, Romain Mangone, Graziella Gaurav, Rahul Pyatigorskaya, Nadya Hutchison, Matthew Yahia-Cherif, Lydia Villain, Nicolas Habert, Marie-Odile Arnulf, Isabelle Leu-Semenescu, Smaranda Dodet, Pauline Vila, Miquel Corvol, Jean-Christophe Vidailhet, Marie Lehéricy, Stéphane Brain Original Articles In Parkinson’s disease, there is a progressive reduction in striatal dopaminergic function, and loss of neuromelanin-containing dopaminergic neurons and increased iron deposition in the substantia nigra. We tested the hypothesis of a relationship between impairment of the dopaminergic system and changes in the iron metabolism. Based on imaging data of patients with prodromal and early clinical Parkinson’s disease, we assessed the spatiotemporal ordering of such changes and relationships in the sensorimotor, associative and limbic territories of the nigrostriatal system. Patients with Parkinson’s disease (disease duration < 4 years) or idiopathic REM sleep behaviour disorder (a prodromal form of Parkinson’s disease) and healthy controls underwent longitudinal examination (baseline and 2-year follow-up). Neuromelanin and iron sensitive MRI and dopamine transporter single-photon emission tomography were performed to assess nigrostriatal levels of neuromelanin, iron, and dopamine. For all three functional territories of the nigrostriatal system, in the clinically most and least affected hemispheres separately, the following was performed: cross-sectional and longitudinal intergroup difference analysis of striatal dopamine and iron, and nigral neuromelanin and iron; in Parkinson’s disease patients, exponential fitting analysis to assess the duration of the prodromal phase and the temporal ordering of changes in dopamine, neuromelanin or iron relative to controls; and voxel-wise correlation analysis to investigate concomitant spatial changes in dopamine-iron, dopamine-neuromelanin and neuromelanin-iron in the substantia nigra pars compacta. The temporal ordering of dopaminergic changes followed the known spatial pattern of progression involving first the sensorimotor, then the associative and limbic striatal and nigral regions. Striatal dopaminergic denervation occurred first followed by abnormal iron metabolism and finally neuromelanin changes in the substantia nigra pars compacta, which followed the same spatial and temporal gradient observed in the striatum but shifted in time. In conclusion, dopaminergic striatal dysfunction and cell loss in the substantia nigra pars compacta are interrelated with increased nigral iron content. Oxford University Press 2021-05-12 /pmc/articles/PMC8634084/ /pubmed/33978742 http://dx.doi.org/10.1093/brain/awab191 Text en © The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Articles
Biondetti, Emma
Santin, Mathieu D
Valabrègue, Romain
Mangone, Graziella
Gaurav, Rahul
Pyatigorskaya, Nadya
Hutchison, Matthew
Yahia-Cherif, Lydia
Villain, Nicolas
Habert, Marie-Odile
Arnulf, Isabelle
Leu-Semenescu, Smaranda
Dodet, Pauline
Vila, Miquel
Corvol, Jean-Christophe
Vidailhet, Marie
Lehéricy, Stéphane
The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease
title The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease
title_full The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease
title_fullStr The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease
title_full_unstemmed The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease
title_short The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease
title_sort spatiotemporal changes in dopamine, neuromelanin and iron characterizing parkinson’s disease
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634084/
https://www.ncbi.nlm.nih.gov/pubmed/33978742
http://dx.doi.org/10.1093/brain/awab191
work_keys_str_mv AT biondettiemma thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT santinmathieud thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT valabregueromain thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT mangonegraziella thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT gauravrahul thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT pyatigorskayanadya thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT hutchisonmatthew thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT yahiacheriflydia thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT villainnicolas thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT habertmarieodile thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT arnulfisabelle thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT leusemenescusmaranda thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT dodetpauline thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT vilamiquel thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT corvoljeanchristophe thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT vidailhetmarie thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT lehericystephane thespatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT biondettiemma spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT santinmathieud spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT valabregueromain spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT mangonegraziella spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT gauravrahul spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT pyatigorskayanadya spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT hutchisonmatthew spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT yahiacheriflydia spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT villainnicolas spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT habertmarieodile spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT arnulfisabelle spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT leusemenescusmaranda spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT dodetpauline spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT vilamiquel spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT corvoljeanchristophe spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT vidailhetmarie spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease
AT lehericystephane spatiotemporalchangesindopamineneuromelaninandironcharacterizingparkinsonsdisease